| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 97,822 | 98,028 | 88,403 | 104,619 | | Cost of Revenue | 67,384 | 65,703 | 61,173 | 68,701 | | | Gross Profit | 30,438 | 32,325 | 27,230 | 35,918 | | | Operating Expenses | | Research Development | 919 | 1,096 | 1,185 | 1,190 | | Selling General and Administrative | 24,830 | 25,464 | 26,496 | 27,925 | | Non Recurring | 1,340 | 1,645 | 993 | 121,167 | | Others | 2,668 | 2,534 | 2,521 | 3,199 | | | | Total Operating Expenses | 29,757 | 30,739 | 31,195 | 153,481 | | | | Operating Income or Loss | 814 | 1,586 | (3,965) | (117,563) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (2,971) | (700) | 54 | (842) | | Earnings Before Interest And Taxes | (2,290) | 886 | (3,911) | (118,405) | | Interest Expense | 337 | 510 | 581 | 906 | | Income Before Tax | (2,627) | 376 | (4,492) | (119,311) | | Income Tax Expense | (1,612) | 624 | 584 | (368) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (1,015) | (248) | (5,076) | (118,943) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (1,015) | (248) | (5,076) | (118,943) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($1,015) | ($248) | ($5,076) | ($118,943) |
|
0.03% Nasdaq 
Income Statement
